Similar to the KEMU study cohort, the Sucrosomial B12 formulation resulted in a significant increase in circulatory vitamin B12 levels from day 1 compared to baseline ( p 0.015), with levels continuing to increase until day 5
(ACTIVATOR): Aqua (Water), Glycerin, Tripeptide-29, Tripeptide-1, Myristoyl Nonapeptide-3, Trifluoroacetyl Tripeptide-2, Acetyl Tetrapeptide-2, Sodium Hyaluronate Crosspolymer, Glycogen, Propanediol, Pentylene Glycol, Dextran, Dimethyl Isosorbide, Ethoxydiglycol, Isoceteth-20, Leuconostoc/Radish Root Ferment Filtrate, Caprylyl Glycol, Ethylhexylglycerin, Phenoxyethanol, Chlorphenesin
Most protocols recommend morning injection
Treatment effects were assessed using the ANOVA linear mixed-effects model (treatment as a fixed effect and subject as a random effect)
(5) At least 53 of the 91 toxins found in the average person suppress the immune system